EMERYVILLE, Calif.—NovaBay Pharmaceuticals (NYSE MKT: NBY) last week received 510(k) clearance from the U.S. Food and Drug Administration (FDA) to market its intelli-Case with hydrogen peroxide solutions.

Although hydrogen peroxide solutions are considered by many eyecare practitioners to be a desirable disinfection solution, it is only used by about 10 percent of the more than 24 million Americans who disinfect their contact lenses with a disinfection system because it can be tricky to use, NovaBay said.

The intelli-Case monitors the neutralization of hydrogen peroxide during the disinfection cycle with microprocessor electronics embedded in the cap of what otherwise looks like a standard peroxide lens case. The cap has three LED lights labeled Unsafe, Busy and Ready. Lenses are placed into the case with hydrogen peroxide solution. The green Ready light blinks when lenses are safe to insert into the eyes and continues to blink green until contact lenses are removed from the case.

“The intelli-Case is a highly innovative, extremely easy-to-use device for the millions of Americans who wear contact lenses and want to use the best disinfection system,” said Ron Najafi, Ph.D., NovaBay’s president and CEO. “We believe that intelli-Case can revolutionize contact lens care by making the peroxide disinfection system as simple as using multipurpose solutions.”